{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:29:17Z","timestamp":1791944957277,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1006\/taap.1999.8807","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T18:01:25Z","timestamp":1032372085000},"page":"283-293","source":"Crossref","is-referenced-by-count":37,"title":["Efficacy of Succimer Chelation for Reducing Brain Lead in a Primate Model of Human Lead Exposure"],"prefix":"10.1006","volume":"161","author":[{"suffix":"Jr.","given":"J.D.","family":"Cremin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Luck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.K.","family":"Laughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/taap.1999.8807_RF1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.pa.30.040190.001431","article-title":"Meso-2,3-dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent","volume":"30","author":"Aposhian","year":"1990","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1006\/taap.1999.8807_RF2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/enrs.1994.1069","article-title":"The impact of soil lead abatement on urban children's blood lead levels: phase II results from the Boston Lead-In-Soil Demonstration Project","volume":"67","author":"Aschengrau","year":"1994","journal-title":"Environ. Res."},{"key":"10.1006\/taap.1999.8807_RF3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/15563659209017937","article-title":"BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children","volume":"30","author":"Chisolm","year":"1992","journal-title":"Clin. Toxicol."},{"key":"10.1006\/taap.1999.8807_RF4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0041-008X(82)90014-X","article-title":"Lead in blood and brain regions of rats chronically exposed to low doses of the metal","volume":"65","author":"Collins","year":"1982","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.1999.8807_RF5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ddr.430250302","article-title":"Overview of the CNS pharmacology of BW 137OU87: a chemically novel, reversible, selective MAO-A inhibitor with potential to be a new antidepressant drug","volume":"25","author":"Cooper","year":"1992","journal-title":"Drug. Dev. Res."},{"key":"10.1006\/taap.1999.8807_RF6","first-page":"84","article-title":"Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy","volume":"246","author":"Cory-Slechta","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/taap.1999.8807_RF7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.pa.35.040195.002135","article-title":"Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions","volume":"35","author":"Cory-Slechta","year":"1995","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1006\/taap.1999.8807_RF8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/jcbfm.1983.35","article-title":"Regional brain blood flow, blood volume, and haematocrit values in the adult rat","volume":"3","author":"Cremer","year":"1983","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1006\/taap.1999.8807_RF9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3476(94)70217-9","article-title":"Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults","volume":"125","author":"Dart","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1006\/taap.1999.8807_RF10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0165-0173(98)00011-3","article-title":"Low-level lead-induced neurotoxicity in children: an update on central nervous system effects","volume":"27","author":"Finkelstein","year":"1998","journal-title":"Brain Res. Rev."},{"key":"10.1006\/taap.1999.8807_RF11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/faat.1995.1059","article-title":"Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats","volume":"25","author":"Flora","year":"1995","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1006\/taap.1999.8807_RF12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00002018-199309020-00002","article-title":"The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning","volume":"9","author":"Glotzer","year":"1993","journal-title":"Drug Safety"},{"key":"10.1006\/taap.1999.8807_RF13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneur.1974.00490420048005","article-title":"Pathogenesis of lead encephalopathy","volume":"31","author":"Goldstein","year":"1974","journal-title":"Arch. Neurol."},{"key":"10.1006\/taap.1999.8807_RF14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF03259834","article-title":"Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning","volume":"1","author":"Graziano","year":"1986","journal-title":"Med. Toxicol."},{"key":"10.1006\/taap.1999.8807_RF15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3476(88)80396-2","article-title":"Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations","volume":"113","author":"Graziano","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1006\/taap.1999.8807_RF16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3476(05)80618-3","article-title":"Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication","volume":"120","author":"Graziano","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1006\/taap.1999.8807_RF17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/clpt.1985.67","article-title":"2,3-Dimercaptosuccinic acid as an antidote for lead intoxication","volume":"37","author":"Graziano","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1006\/taap.1999.8807_RF18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0300-483X(94)90217-8","article-title":"Effect of chelate treatments on kidney, bone, and brain lead levels of lead-intoxicated mice","volume":"89","author":"Jones","year":"1994","journal-title":"Toxicology"},{"key":"10.1006\/taap.1999.8807_RF19","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/0278-5846(90)90092-U","article-title":"The behavioral neurobiology of self-injurious behavior in rhesus monkeys","volume":"14","author":"Kraemer","year":"1990","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiat."},{"key":"10.1006\/taap.1999.8807_RF20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0893-133X(89)90021-3","article-title":"A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys","volume":"2","author":"Kraemer","year":"1989","journal-title":"Neuropsychopharmacology"},{"key":"10.1006\/taap.1999.8807_RF21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1997.tb52353.x","article-title":"The behavioral neurobiology of self-injurious behavior in rhesus monkeys: current concepts and relations to impulsive behavior in humans","volume":"836","author":"Kraemer","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1006\/taap.1999.8807_RF22","doi-asserted-by":"crossref","DOI":"10.1016\/S0892-0362(99)00036-7","article-title":"Lead effects on development in the neonatal rhesus monkey (Macaca mulatta)","author":"Laughlin","year":"1999","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1006\/taap.1999.8807_RF23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1289\/ehp.93101598","article-title":"An age-specific kinetic model of lead metabolism in humans","volume":"101","author":"Leggett","year":"1993","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/taap.1999.8807_RF24","first-page":"197","article-title":"Regional distribution of 203PbCl2 in the mouse after intravenous injection","volume":"19","author":"Lever","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1006\/taap.1999.8807_RF25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3476(94)70326-4","article-title":"Efficacy of oral meso-2,3-dimercaptosuccinic acid therapy for low-level childhood plumbism","volume":"124","author":"Liebelt","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1006\/taap.1999.8807_RF26","first-page":"169","article-title":"Biological behavior and metabolic fate of the BAL analogues DMSA and DMPS","volume":"27","author":"McGown","year":"1984","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"10.1006\/taap.1999.8807_RF27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1289\/ehp.106-1533171","article-title":"Prevalence of elevated blood lead levels in an inner-city pediatric clinic population","volume":"106","author":"Melman","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/taap.1999.8807_RF28","first-page":"440","article-title":"Blood-brain barrier, cerebral blood flow, and cerebral plasma volume immediately after head injury in the rat","volume":"60","author":"Nawashiro","year":"1994","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1006\/taap.1999.8807_RF29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jama.1996.03530290033034","article-title":"Bone lead levels and delinquent behavior","volume":"275","author":"Needleman","year":"1996","journal-title":"JAMA"},{"key":"10.1006\/taap.1999.8807_RF30","unstructured":"NRC. 1996. Guide for the Care and Use of Laboratory Animals. National Research Council, National Academy Press, Washington, DC, 1996, pp. 1\u2013125."},{"key":"10.1006\/taap.1999.8807_RF31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1997.8328","article-title":"Evaluation and modification of a physiologically based model of lead kinetics using data from a sequential isotope study in cynomolgus monkeys","volume":"149","author":"O'Flaherty","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.1999.8807_RF32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/taap.1996.0105","article-title":"Plasma and blood lead concentrations, lead absorption, and lead excretion in nonhuman primates","volume":"138","author":"O'Flaherty","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.1999.8807_RF33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/taap.1995.1133","article-title":"Oral dimercaptosuccinic acid and ongoing exposure to lead: effects on heme synthesis and lead distribution in a rat model","volume":"133","author":"Pappas","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.1999.8807_RF34","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.1975.03260240058029","article-title":"Cerebral blood volume in man","volume":"234","author":"Penn","year":"1975","journal-title":"JAMA"},{"key":"10.1006\/taap.1999.8807_RF35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1289\/ehp.98106745","article-title":"Exposure of the U.S. population to lead, 1991\u20131994","volume":"106","author":"Pirkle","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/taap.1999.8807_RF36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-510X(96)00300-0","article-title":"Quantification of trace elements in normal human brain by inductively coupled plasma atomic emission spectrometry","volume":"146","author":"Rajan","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/taap.1999.8807_RF37","first-page":"167","article-title":"Lead-induced changes in learning: evidence for behavioral mechanisms from experimental animal studies","volume":"14","author":"Rice","year":"1993","journal-title":"Neurotoxicology"},{"key":"10.1006\/taap.1999.8807_RF38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1289\/ehp.96104s2337","article-title":"Behavioral effects of lead: commonalities between experimental and epidemiologic data","volume":"104","author":"Rice","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/taap.1999.8807_RF39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1289\/ehp.95103s673","article-title":"Developing brain as a target of toxicity","volume":"103","author":"Rodier","year":"1995","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/taap.1999.8807_RF40","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.1993.03500130055032","article-title":"Declining blood lead levels and cognitive changes in moderately lead-poisoned children","volume":"269","author":"Ruff","year":"1993","journal-title":"JAMA"},{"key":"10.1006\/taap.1999.8807_RF41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/enrs.1998.3854","article-title":"Efficacy of succimer chelation for reducing brain Pb levels in a rodent model","volume":"78","author":"Smith","year":"1998","journal-title":"Environ. Res."},{"key":"10.1006\/taap.1999.8807_RF42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0041-008X(92)90148-L","article-title":"Stable isotopic tracers of lead mobilized by DMSA chelation in low lead-exposed rats","volume":"116","author":"Smith","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.1999.8807_RF43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/enrs.1994.1063","article-title":"The effects of succimer on the absorption of lead in adults determined by using the stable isotope 204Pb","volume":"67","author":"Smith","year":"1994","journal-title":"Environ. Res."},{"key":"10.1006\/taap.1999.8807_RF44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0013-9351(05)80079-9","article-title":"Stable isotope labeling of lead compartments in rats with ultra-low lead concentrations","volume":"57","author":"Smith","year":"1992","journal-title":"Environ. Res."},{"key":"10.1006\/taap.1999.8807_RF45","unstructured":"SAS Institute1989. SAS\/STAT User's Guide. Version 6, 4th ed., SAS Institute, Inc. Cary, NC."},{"key":"10.1006\/taap.1999.8807_RF46","doi-asserted-by":"crossref","unstructured":"TLC (The Treatment of Lead-exposed Children Trial Group). (1998). The Treatment of Lead-exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlers. Paediatr. Perinatal Epidemiol.12, 313\u2013333.","DOI":"10.1046\/j.1365-3016.1998.00122.x"},{"key":"10.1006\/taap.1999.8807_RF47","unstructured":"U.S. Environmental Protection Agency (EPA) (1998), Review of Studies Addressing Lead Abatement Effectiveness., EPA 747-B-98-001, U.S. Environmental Protection Agency, Washington, DC."},{"key":"10.1006\/taap.1999.8807_RF48","first-page":"295","article-title":"Homogeneity of regional brain lead concentrations","volume":"15","author":"Widzowski","year":"1994","journal-title":"Neurotoxicology"},{"key":"10.1006\/taap.1999.8807_RF49","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1039\/a803145b","article-title":"An inductively coupled plasma\u2014magnetic sector mass spectrometry method for stable lead isotope tracer studies","volume":"13","author":"Woolard","year":"1998","journal-title":"J. Anal. At. Spect."},{"key":"10.1006\/taap.1999.8807_RF50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0300-483X(88)90220-X","article-title":"Comparative mobilization of lead by chelating agents","volume":"53","author":"Xu","year":"1988","journal-title":"Toxicology"},{"key":"10.1006\/taap.1999.8807_RF51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/taap.1998.8396","article-title":"Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment","volume":"150","author":"Zuch","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X99988075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X99988075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T05:15:35Z","timestamp":1576559735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X99988075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S0041008X99988075"],"URL":"https:\/\/doi.org\/10.1006\/taap.1999.8807","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}